In this issue:
Teprotumumab for thyroid-associated ophthalmopathy
Factors affecting mortality in Graves’ ophthalmopathy
Efficacy of 2nd antithyroid drug treatment in relapsed Graves’ disease
Pre-conception TSH and pregnancy outcomes
Extent of surgery & recurrence in papillary thyroid cancer sized 1-4 cm
Overnight metyrapone test to assess HPA axis function after pituitary surgery
Impaired QoL remains long-term in treated, biochemically stable acromegaly
Temozolomide improves OS in aggressive pituitary tumours
Primary aldosteronism as a risk factor for vertebral fracture
Thiazide treatment in primary hyperparathyroidism
Please login below to download this issue (PDF)